Ferrer inCode SL-Product Pipeline Analysis, 2017 Update

Region:Europe

Author(s):

Product Code:GDME172910PD

Download Sample Report download
Buy the Full ReportStarting from $750
Published on

April 2017

Total pages

22

Table of Content

Download Sample Report download
Buy the Full ReportStarting from $750

About the Report

About the Report

Summary

Ferrer inCode SL (Ferrer), a subsidiary of Grupo Ferrer Internacional SA is a provider of molecular diagnostics and personalized medicine solutions. The company offers biotechnological solutions to make clinical decisions for patients. Its products comprise microarray-based gene expression test, multigene profile, prognosis and predictive tool, expression panel, diagnostic tools and others. Ferrer promotes and grants access to personalized medicine through prognosis, diagnosis, and prediction based in genomics, proteomics, metabolomics, and bioinformatics technology. The company offers treatment for oncological, cardiovascular and CNS diseases. Ferrer is headquartered in Barcelona, Spain.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

The report analyzes all pipeline products in development for the company Ferrer inCode SL

The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

The report provides detailed description of products in development, technical specification and functions

The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

To formulate effective Research & Development strategies

Develop market-entry and market expansion strategies

Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Products

Products

Ferrer inCode SL, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies

Table of Contents

Table of Contents

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 3

Ferrer inCode SL Company Overview 4

Ferrer inCode SL Company Snapshot 4

Ferrer inCode SL Pipeline Products and Ongoing Clinical Trials Overview 4

Ferrer inCode SL-Pipeline Analysis Overview 7

Ferrer inCode SL-Key Facts 7

Ferrer inCode SL-Major Products and Services 8

Ferrer inCode SL Pipeline Products by Development Stage 9

Ferrer inCode SL Pipeline Products Overview 11

DAP 11

DAP Product Overview 11

FAB-118 12

FAB-118 Product Overview 12

StrokeChip 13

StrokeChip Product Overview 13

VHC-Core 14

VHC-Core Product Overview 14

Ferrer inCode SL-Key Competitors 15

Ferrer inCode SL-Key Employees 16

Ferrer inCode SL-Locations And Subsidiaries 17

Head Office 17

Recent Developments 18

Ferrer inCode SL, Recent Developments 18

Aug 27, 2016: The first epigenetic test to identify tumors of unknown primary 18

Appendix 19

Methodology 19

About GlobalData 21

Contact Us 21

Disclaimer 21


List of Figure

List of Figures

Ferrer inCode SL Pipeline Products by Equipment Type 5

Ferrer inCode SL Pipeline Products by Development Stage 9


List of Table

List of Tables

Ferrer inCode SL Pipeline Products and Ongoing Clinical Trials Overview 4

Ferrer inCode SL Pipeline Products by Equipment Type 5

Ferrer inCode SL Pipeline Products by Indication 6

Ferrer inCode SL, Key Facts 7

Ferrer inCode SL, Major Products and Services 8

Ferrer inCode SL Number of Pipeline Products by Development Stage 9

Ferrer inCode SL Pipeline Products Summary by Development Stage 10

DAP-Product Status 11

DAP-Product Description 11

FAB-118-Product Status 12

FAB-118-Product Description 12

StrokeChip-Product Status 13

StrokeChip-Product Description 13

VHC-Core-Product Status 14

VHC-Core-Product Description 14

Ferrer inCode SL, Key Employees 16

Glossary 20

You can also purchase parts of this report.
Do you want to check out a section wise price list?
Get Price Break-up

Why Buy From US?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository
150+ Consulting project a year
100+ Analysts
8000+ Client Queries in 2022